Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC (NPC)

This study has been completed.
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Helen Heslop, Baylor College of Medicine Identifier:
First received: February 2, 2008
Last updated: October 5, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)